UK markets closed

Cellectis S.A. (CLLS)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
2.6500-0.0200 (-0.75%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 193.01M
Enterprise value 209.60M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)8.37
Price/book (mrq)2.50
Enterprise value/revenue 12.71
Enterprise value/EBITDA -3.76

Trading information

Stock price history

Beta (5Y monthly) 3.13
52-week change 337.31%
S&P500 52-week change 327.86%
52-week high 33.7740
52-week low 30.9630
50-day moving average 32.7340
200-day moving average 32.3324

Share statistics

Avg vol (3-month) 342.64k
Avg vol (10-day) 325.23k
Shares outstanding 571.75M
Implied shares outstanding 672.17M
Float 833.22M
% held by insiders 112.13%
% held by institutions 118.81%
Shares short (15 Mar 2024) 4679.27k
Short ratio (15 Mar 2024) 414.65
Short % of float (15 Mar 2024) 4N/A
Short % of shares outstanding (15 Mar 2024) 40.95%
Shares short (prior month 15 Feb 2024) 4728.16k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,257.30%

Management effectiveness

Return on assets (ttm)-18.78%
Return on equity (ttm)-71.28%

Income statement

Revenue (ttm)24.52M
Revenue per share (ttm)0.47
Quarterly revenue growth (yoy)-12.50%
Gross profit (ttm)N/A
EBITDA -62.82M
Net income avi to common (ttm)-71.89M
Diluted EPS (ttm)-1.4100
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)67.36M
Total cash per share (mrq)1.21
Total debt (mrq)83.53M
Total debt/equity (mrq)109.72%
Current ratio (mrq)2.19
Book value per share (mrq)1.37

Cash flow statement

Operating cash flow (ttm)-65.68M
Levered free cash flow (ttm)-48.23M